A paradigm shift in platelet transfusion therapy
- PMID: 26045593
- PMCID: PMC4458795
- DOI: 10.1182/blood-2015-04-640649
A paradigm shift in platelet transfusion therapy
Abstract
In this issue of Blood, Wang et al report that ex vivo–derived human megakaryocytes infused into mice are trapped in the pulmonary vasculature and release functional platelets into the circulation. Because of the difficulty in scalable generation of ex vivo–derived functional platelets, this strategy may be a substitute for platelet transfusion therapy.
Conflict of interest statement
Conflict-of-interest disclosure: The author declares no competing financial interests.
Figures
Comment on
-
Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale.Blood. 2015 Jun 4;125(23):3627-36. doi: 10.1182/blood-2014-08-593053. Epub 2015 Apr 7. Blood. 2015. PMID: 25852052 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
